-- アナエルジア（ANRG.TO）は水曜日、子会社のアナエルジア・テクノロジーズを通じて、ヴァンガード・リニューアブルズと800万カナダドルの契約を締結したと発表した。この契約は、ミネソタ州に建設中の高度嫌気性消化施設向けに、アナエルジア独自の技術と設備を導入するものだ。 これは、アナエルジアがヴァンガード・リニューアブルズに技術を導入する4例目となる。 アナエルジア・テクノロジーズは、独自のプロセス技術、永久同期磁石ミキサー、バイオガス精製システムを含むプラットフォームを提供する。 ヴァンガード・リニューアブルズは、このプラットフォームを用いて、食品、飲料、農業廃棄物を処理し、地域のエネルギー供給システムに注入する再生可能天然ガスを生産する予定だ。
Related Articles
Research
KeyBanc Upgrades MSC Industrial Direct to Overweight From Sector Weight, Sets $117 Price Target
MSC Industrial Direct (MSM) has an average rating of hold and mean price target of $98.80, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$MSM
International
Earnings Season, Tehran Proposal Lift Asian Stock Markets
Asian stock markets largely gained ground Monday on strength in tech issues, and on media reports that Tehran has floated a proposal to reopen the Strait of Hormuz. A generally good industrial profits report from Beijing also boosted sentiments.Shanghai and Tokyo finished in the green, while Hong Kong edged lower. Other regional exchanges mostly finished higher.In Japan, the Nikkei 225 opened evenly but rose to the close, gaining 1.4% to strike a fresh all-time high. Strong earnings results offset a risk-off mood.The benchmark Nikkei 225 index rose 821.18 to 60,537.36, the first-ever close above the 60,000-milestone, although losing issues outnumbered gainers 129 to 94.Leading the upside was industrial robot maker Fanuc, up 16%, while Chugai Pharmaceutical declined 15.8%, with both moves following earnings reports.In Hong Kong, the Hang Seng Index finished off 0.2%, undercut by property issues.The broad gauge Hang Seng fell 52.42 to 25,925.65, as losing issues outnumbered gainers 53 to 36. The Hang Seng TECH Index gained 0.8% on the day, while the Mainland Properties Index fell 0.7%.Leading the upside was Semiconductor Manufacturing International, gaining 6.1%, while Sinopharm declined 3.8%.On the mainland, the Shanghai Composite rose 0.2% to 4,086.34.In economic news, industrial profits in China rose 15.8% on the year in March, largely on the back of private-sector enterprises, said the National Bureau of Statistics. The agency's survey is limited to companies with more than $2.9 million a year in revenue.On the other regional exchanges, the South Korean KOSPI rose 2.2%; the Taiwan TWSE advanced 1.8%; the Australian ASX 200 declined 0.2%; the Singapore Straits Times Index fell 0.6%, and the Thai Set rose 1.6%. In late trading in Mumbai, the Sensex was up 0.8%The MSCI All Country Asia Pacific Index rose 1.2% on the day.
$^HSI$^N225$^SSEC
Research
Morgan Stanley Resumes BioMarin Pharmaceutical at Overweight With $120 Price Target
BioMarin Pharmaceutical (BMRN) has an average rating of overweight and mean price target of $90.17, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$BMRN